Correlation Between Revelation Biosciences and ARCA Biopharma
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and ARCA Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and ARCA Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and ARCA Biopharma, you can compare the effects of market volatilities on Revelation Biosciences and ARCA Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of ARCA Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and ARCA Biopharma.
Diversification Opportunities for Revelation Biosciences and ARCA Biopharma
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Revelation and ARCA is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and ARCA Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ARCA Biopharma and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with ARCA Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ARCA Biopharma has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and ARCA Biopharma go up and down completely randomly.
Pair Corralation between Revelation Biosciences and ARCA Biopharma
If you would invest (100.00) in ARCA Biopharma on August 28, 2024 and sell it today you would earn a total of 100.00 from holding ARCA Biopharma or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Revelation Biosciences vs. ARCA Biopharma
Performance |
| Timeline |
| Revelation Biosciences |
| ARCA Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Revelation Biosciences and ARCA Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revelation Biosciences and ARCA Biopharma
The main advantage of trading using opposite Revelation Biosciences and ARCA Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, ARCA Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ARCA Biopharma will offset losses from the drop in ARCA Biopharma's long position.| Revelation Biosciences vs. Eliem Therapeutics | Revelation Biosciences vs. HCW Biologics | Revelation Biosciences vs. Scpharmaceuticals | Revelation Biosciences vs. Milestone Pharmaceuticals |
| ARCA Biopharma vs. Aerovate Therapeutics | ARCA Biopharma vs. Adagene | ARCA Biopharma vs. Acrivon Therapeutics, Common | ARCA Biopharma vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |